| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 09/29/2011 | US20110237595 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 09/29/2011 | DE102010013068A1 Verbindungen für elektronische Vorrichtungen Compounds for electronic devices |
| 09/28/2011 | EP2368880A1 6-(Heterocycle-Substituted Benzyl)-4-Oxoquinoline Compound and Use of the Same as HIV Integrase Inhibitor |
| 09/28/2011 | EP2367796A1 Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino }-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor |
| 09/28/2011 | EP2367795A1 Methods of preparing quinoline derivatives |
| 09/28/2011 | EP2367794A1 Curable composition comprising a thermolatent base |
| 09/28/2011 | CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/28/2011 | CN102203066A Novel dyes and use thereof in imaging members and methods |
| 09/28/2011 | CN102203065A Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists |
| 09/28/2011 | CN101638382B Method for preparing 7-chloroquinaldine by utilizing phase-transfer reaction |
| 09/28/2011 | CN101440062B Synthesis of N-acyl-8-amino quinoline derivatives and use thereof as fluorescent molecular probe |
| 09/28/2011 | CN101353447B Synthetic process of rubber antiager RD |
| 09/28/2011 | CN101087760B Crystalline aripiprazole solvates |
| 09/27/2011 | US8026371 Hydroxamates as therapeutic agents |
| 09/27/2011 | US8026364 NK1 antagonists |
| 09/27/2011 | US8026258 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 09/27/2011 | US8026239 Cell differentiation inducer |
| 09/22/2011 | WO2011116397A1 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 09/22/2011 | WO2011115378A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/22/2011 | WO2011114099A1 Purification tags of synthetic peptides and proteins |
| 09/22/2011 | US20110230662 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 09/22/2011 | US20110230520 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases |
| 09/22/2011 | US20110230519 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 09/22/2011 | US20110230491 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 09/22/2011 | US20110230488 Hybrid-ionone and curcumin molecules as anticancer agents |
| 09/22/2011 | US20110230446 Cathepsin cysteine protease inhibitors |
| 09/22/2011 | CA2792207A1 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 09/21/2011 | EP1798222B1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery |
| 09/21/2011 | CN102197017A Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders |
| 09/21/2011 | CN102190675A 8-hydroxyquinoline yttrium imine complexes, and preparation method and application thereof |
| 09/21/2011 | CN102190617A Complexometric reagent as well as preparation method and application thereof |
| 09/21/2011 | CN101740723B Organic electroluminescent device and preparation method thereof |
| 09/20/2011 | US8022218 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives for the treatment of infertility |
| 09/20/2011 | US8022217 Compounds suitable as modulators of HDL |
| 09/20/2011 | US8022216 Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| 09/20/2011 | CA2528228C A method for the preparation of montelukast acid and sodium salt thereof in amorphous form |
| 09/20/2011 | CA2508923C Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 09/20/2011 | CA2471943C .beta.-amyloid protein production-secretion inhibitors |
| 09/20/2011 | CA2440067C Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same |
| 09/20/2011 | CA2439415C Cathepsin cysteine protease inhibitors |
| 09/20/2011 | CA2115828C Calcium receptor active molecules |
| 09/15/2011 | WO2011112896A1 Hydrated crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| 09/15/2011 | WO2011110627A1 New cationic 7-amino-1,2,3,4- tetrahydroquinolines, deying composition comprising a cationic 7-amino-1,2,3,4-tetrahydroquinoline, method and uses. |
| 09/15/2011 | WO2010137032A3 Novel polymorphic forms of elvitegravir and its pharmaceutically acceptable salts |
| 09/15/2011 | US20110224248 Azaquinolones that inhibit prolyl hydroxylase |
| 09/15/2011 | US20110224242 Styrlyquinolines, their process of preparation and their therapeutic uses |
| 09/15/2011 | US20110224207 Flavivirus inhibitors and methods for their use |
| 09/15/2011 | US20110224155 Modulation of chemosensory receptors and ligands associated therewith |
| 09/15/2011 | CA2792852A1 Hydrated crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| 09/14/2011 | EP2365735A2 Luminescent element material and luminescent element comprising the same |
| 09/14/2011 | EP2364706A1 Pharmaceutical agent comprising quinolone compound |
| 09/14/2011 | EP2364298A1 Quinolone compound and pharmaceutical composition |
| 09/14/2011 | EP2364089A1 Heterobicyclic sphingosine 1-phosphate analogs |
| 09/14/2011 | EP2004608B1 An improved process for the manufacture of montelukast sodium |
| 09/14/2011 | EP1809288B1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
| 09/14/2011 | EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof |
| 09/14/2011 | CN102186848A Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 09/14/2011 | CN102186845A S1p receptors modulators and their use thereof |
| 09/14/2011 | CN102186824A Fused-ring derivative and medical application of same |
| 09/14/2011 | CN102180830A 8-hydroxyquinoline derivative, and metal complexes and preparation method thereof |
| 09/14/2011 | CN101506170B 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as HIV integrase inhibitor |
| 09/13/2011 | US8017782 hypogonadism and male infertility; ovulation induction |
| 09/13/2011 | US8017775 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 09/13/2011 | US8017626 Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 09/13/2011 | US8017615 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2011 | CA2615921C Hepatitis c inhibitor peptide analogs with a quinoline or a thienopyridine moiety |
| 09/13/2011 | CA2560402C Tetrahydroquinoline derivatives and a process for preparing the same |
| 09/13/2011 | CA2508952C Tetrahydroquinoline derivatives and their use as follicle stimulating hormone receptor modulators |
| 09/13/2011 | CA2452606C Tetrahydroquinoline derivatives |
| 09/13/2011 | CA2425268C Pyridinone derivatives for treatment of atherosclerosis |
| 09/09/2011 | WO2011107709A1 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same |
| 09/09/2011 | CA2791490A1 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same |
| 09/08/2011 | US20110218208 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 09/07/2011 | EP2363399A1 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 09/07/2011 | EP1877383B1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 09/07/2011 | CN1817882B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/07/2011 | CN102174015A Refining method of rebamipide |
| 09/06/2011 | US8013174 Photochromic spirodihydrophenanthropyrans |
| 09/06/2011 | CA2656875C Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 09/06/2011 | CA2493536C 8-hydroxy quinoline derivatives |
| 09/06/2011 | CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/01/2011 | WO2011105649A1 New method for manufacturing pitavastatin hemicalcium using new intermediate |
| 09/01/2011 | WO2011105349A1 Stable crystal form of 2-ethyl-3, 7-dimethyl-6-(4-(trifluoromethoxy) phenoxy)quinoline-4-ylmethyl carbonate, method of manufacturing same and agricultural chemical composition containing crystals of same |
| 09/01/2011 | WO2011070177A3 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
| 09/01/2011 | US20110212989 Therapeutic methods and compositions involving isoflavones |
| 09/01/2011 | US20110212946 Quinolone Neuropeptide S Receptor Antagonists |
| 09/01/2011 | US20110212075 Screening method for polymorphic markers in htra1 gene in neurodegenerative disorders |
| 09/01/2011 | CA2790921A1 Stabilized crystal of 2-ethyl-3,7-dimethyl-6-(4-(trifluoromethoxy)phenoxy)quinoline-4-yl methyl carbonate, process for producing the crystal, and agricultural chemical compositioncomprising the crystal |
| 08/31/2011 | EP2361913A1 Anti-infective agents |
| 08/31/2011 | EP2361245A1 Hybrid -ionone and curcumin molecules as anticancer agents |
| 08/31/2011 | EP1678139B1 Solid-state montelukast |
| 08/31/2011 | EP1506000B9 Heterocyclicsulfonamide hepatitis c virus inhibitors |
| 08/31/2011 | CN102167664A Fluorine-containing rare earth salt and applications thereof |
| 08/31/2011 | CN101570510B Quinoline compound, pharmaceutical composition, preparation method and application thereof |
| 08/31/2011 | CN101490005B Process for the purification of Montelukast |
| 08/31/2011 | CN101219992B Crystalline forms of pitavastatin calcium |
| 08/30/2011 | US8008501 Inhibit the Immunoglobulin E (IgE) receptor signaling cascade; associated with mast and/or basophil cell degranulation such as allergic diseases, scarring, inflammation; e.g. 5-Methyl-3-phenyl-4-isoxazolecarboxylic acid, 2-methyl-4-quinolinyl Ester |
| 08/30/2011 | US8008499 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof |
| 08/30/2011 | US8008498 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 08/30/2011 | US8008497 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |